Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now displayed; this appears to be a minor site revision with no changes to the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No substantive changes to the study information are indicated.SummaryDifference0.1%

- Check27 days agoChange DetectedUI changes include a new 'Show glossary' option and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a system revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; there is no change to the study data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA Locations section has been added with Kentucky as a site. The page revision is updated to v3.3.3, and the former Kentucky Locations entry has been removed.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision: v3.3.2 is now shown, replacing v3.2.0 in the page footer. This is a minor site metadata update that does not affect study details.SummaryDifference0.1%

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.